Iratumumab
Modify Date: 2024-04-02 21:53:16
Iratumumab structure
|
Common Name | Iratumumab | ||
|---|---|---|---|---|
| CAS Number | 640735-09-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IratumumabIratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL)[1]. |
| Name | Iratumumab |
|---|
| Description | Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL)[1]. |
|---|---|
| Related Catalog | |
| Target |
CD30[1] |
| References |
| No Any Chemical & Physical Properties |